Ticker name:ASND Ascendis Pharma A/S
Country: DK-Sector: Healthcare, Industry: Biotechnology
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
- CEO: Jan Moller Mikkelsen
- IPO: Jan 28, 2015
- Website:...ndispharma.com (open a new tab)
Market Cap 15B
Last close 241.34$
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 109B | 430.44$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 68B | 649.76$ | |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 40B | 298.48$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 32B | 150.33$ | |
| 5 | RPRX | Royalty Pharma plc | 31B | 53.06$ | |
| 6 | UTHR | UNITED THERAPEUTICS Corp | 24B | 563.93$ | |
| 7 | INSM | INSMED Inc | 23B | 107.91$ | |
| 8 | ROIV | Roivant Sciences Ltd. | 23B | 32.41$ | |
| 9 | INCY | INCYTE CORP | 19B | 97.08$ | |
| 10 | MRNA | Moderna, Inc. | 19B | 48.12$ | |
| 11 | GMAB | GENMAB A/S | 17B | 27.21$ | |
| 12 | JAZZ | Jazz Pharmaceuticals plc | 15B | 239.01$ | |
| 13 | ASND | Ascendis Pharma A/S | 15B | 241.34$ | |
| 14 | SMMT | Summit Therapeutics Inc. | 14B | 17.89$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13B | 68.22$ | |
| 16 | EXEL | EXELIXIS, INC. | 13B | 49.9$ | |
| 17 | IONS | IONIS PHARMACEUTICALS INC | 12B | 75.06$ | |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12B | 230.62$ | |
| 19 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 513.47$ | |
| 20 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 11B | 77.14$ |